Editas Medicine Inc (EDIT)
5.455
+0.24
(+4.70%)
USD |
NASDAQ |
May 01, 16:00
5.46
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine Total Return Level: 5.455 for May 1, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 01, 2024 | 5.455 |
April 30, 2024 | 5.21 |
April 29, 2024 | 5.37 |
April 26, 2024 | 5.32 |
April 25, 2024 | 5.22 |
April 24, 2024 | 5.35 |
April 23, 2024 | 5.46 |
April 22, 2024 | 5.60 |
April 19, 2024 | 5.49 |
April 18, 2024 | 5.55 |
April 17, 2024 | 5.61 |
April 16, 2024 | 5.85 |
April 15, 2024 | 6.08 |
April 12, 2024 | 6.21 |
April 11, 2024 | 6.58 |
April 10, 2024 | 6.63 |
April 09, 2024 | 7.01 |
April 08, 2024 | 6.72 |
April 05, 2024 | 6.72 |
April 04, 2024 | 6.81 |
April 03, 2024 | 6.86 |
April 02, 2024 | 6.87 |
April 01, 2024 | 7.28 |
March 28, 2024 | 7.42 |
March 27, 2024 | 7.44 |
Date | Value |
---|---|
March 26, 2024 | 7.22 |
March 25, 2024 | 7.36 |
March 22, 2024 | 7.47 |
March 21, 2024 | 7.83 |
March 20, 2024 | 7.92 |
March 19, 2024 | 7.75 |
March 18, 2024 | 7.72 |
March 15, 2024 | 8.13 |
March 14, 2024 | 8.15 |
March 13, 2024 | 8.59 |
March 12, 2024 | 8.61 |
March 11, 2024 | 9.00 |
March 08, 2024 | 9.16 |
March 07, 2024 | 8.85 |
March 06, 2024 | 9.08 |
March 05, 2024 | 9.14 |
March 04, 2024 | 9.92 |
March 01, 2024 | 10.53 |
February 29, 2024 | 10.06 |
February 28, 2024 | 11.07 |
February 27, 2024 | 8.86 |
February 26, 2024 | 8.06 |
February 23, 2024 | 7.81 |
February 22, 2024 | 7.93 |
February 21, 2024 | 8.01 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
5.21
Minimum
Apr 30 2024
90.58
Maximum
Jan 08 2021
23.86
Average
21.45
Median
May 20 2019
Total Return Level Benchmarks
Vertex Pharmaceuticals Inc | 402.18 |
Moderna Inc | 111.46 |
Amicus Therapeutics Inc | 10.42 |
Geron Corp | 4.075 |
Regeneron Pharmaceuticals Inc | 903.02 |